Drug search by name

Sildenafil Oral Suspension (PAH) and Liver disease

Result of checking the interaction of drug Sildenafil Oral Suspension (PAH) and disease Liver disease for safety when used together.

Check result:

Sildenafil Oral Suspension (PAH) <> Liver disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Phosphodiesterase 5 (PDE-5) inhibitors are cleared predominantly by hepatic metabolism. The pharmacokinetic disposition of these agents has not been assessed in patients with severe hepatic impairment. No dosage modification is recommended for patients with mild to moderate hepatic impairment, however, therapy with these agents should not be administered to patients with severe hepatic impairment. In patients with mild hepatic impairment a lower dose of these agents should be used as initial therapy.

Sildenafil Oral Suspension (PAH)

Generic Name: sildenafil

Brand Name: Revatio, Viagra

Synonyms: Sildenafil

What is Sildenafil Oral Suspension (PAH)?